Difference between revisions of "Team:Slovenia/Protease signaling/Split proteases"

Line 90: Line 90:
 
<a href="https://2016.igem.org/Team:Slovenia/Mechanosensing/CaDependent_mediator"> calmodulin-M13 interaction </a>, that we used to detect mechanosensing.
 
<a href="https://2016.igem.org/Team:Slovenia/Mechanosensing/CaDependent_mediator"> calmodulin-M13 interaction </a>, that we used to detect mechanosensing.
 
</p>  
 
</p>  
 +
<div class="ui styled fluid accordion">
 +
<div class="title">
 +
<i class="dropdown icon"></i>
 +
Further explanation ...
 +
</div>
 +
<div class="content">
 +
<p>Interactions among different proteins play a key role among all living organisms. Chemically induced dimerization (CID) is one of such interactions,
 +
which allows two different protein domains to dimerize after the addition of a small molecule. The most widely used CID to date is the FKBP/FRB system
 +
which heterodimerizes upon rapamycin addition <x-ref> Inobe2016 </x-ref>.
 +
</p>
 +
<p>Rapamycin is a 31-membered macrolide antifungal antibiotic that was first isolated from the Streptomyces hygroscopicus and binds with high affinity to the
 +
12-kDa FK506 binding protein (FKBP) as well as to a 100-aminoacid domain (E2015 to Q2114) of the mammalian target of rapamycin (mTOR) protein known as the
 +
FKBP-rapamycin binding domain (FRB) (<ref>4.10.1.</ref>)<x-ref>Banaszynski</x-ref>. Besides FKBP/FRB there are also other CID system where small molecules like
 +
gibberellin <x-ref>Murase</x-ref> and coumermycin <x-ref>Farrar2000</x-ref> are used for induced dimerization.
 +
</p>
 +
<div align = "left">
 +
<figure data-ref="4.10.1">
 +
<img class="ui medium image" src="https://static.igem.org/mediawiki/2016/d/dd/T--Slovenia--4.10.1.png">
 +
<figcaption><b>(A) Chemical structure of rapamycin. Binding sites for FRB and FKBP are shown. (B) Schematic presentation of FKBP and FRB binding to
 +
rapamycin</b><br/>text </figcaption>
 +
</figure><x-ref>Banaszynski</x-ref>
 +
</div>
  
 +
</div>
 +
</div>
 
 
 
</div>
 
</div>

Revision as of 21:54, 15 October 2016

Split proteases

nbsp;Split proteases

The split protein system based on the inducible dimerization is an attractive method to regulate the protease activity. Wehr et al. Wehr2006 described a split TEVp expressed as two functionally inactive fragments; the N-terminal (1 – 118 aa) and C-terminal (119 – 242 aa) protease fragments (referred to as cTEVp and nTEVp). When the two fragments were coexpressed as fusion constructs with adjacent dimerization partners, the split TEVp was able to reconstitute and regain its catalytic activity, demonstrating that the activity of split TEVp could be controlled through the ligand induced protein – protein interactions.

Our team hypothesized that the same inducible dimerization approach could also be used with TEVp homologues. We converted all of the tested orthogonal potyviral proteases to split proteases by splitting them at positions corresponding to the position of the previously described split TEV protease. We selected three different types of dimerization domains to induce the activity of the split proteases. The first pair of dimerization domains was the rapamycin responsive FKBP/FRB system Banaszynski , which induces dimerization upon ligand binding. The second pair of dimerization domains was the CRY2PHR/CIBN system, which induces dimerization upon irradiation with blue light. Finally, our third system for dimerization was designed to respond to a Ca2+ influx based on the calmodulin-M13 interaction , that we used to detect mechanosensing.

Further explanation ...

Interactions among different proteins play a key role among all living organisms. Chemically induced dimerization (CID) is one of such interactions, which allows two different protein domains to dimerize after the addition of a small molecule. The most widely used CID to date is the FKBP/FRB system which heterodimerizes upon rapamycin addition Inobe2016 .

Rapamycin is a 31-membered macrolide antifungal antibiotic that was first isolated from the Streptomyces hygroscopicus and binds with high affinity to the 12-kDa FK506 binding protein (FKBP) as well as to a 100-aminoacid domain (E2015 to Q2114) of the mammalian target of rapamycin (mTOR) protein known as the FKBP-rapamycin binding domain (FRB) (4.10.1.)Banaszynski. Besides FKBP/FRB there are also other CID system where small molecules like gibberellin Murase and coumermycin Farrar2000 are used for induced dimerization.

(A) Chemical structure of rapamycin. Binding sites for FRB and FKBP are shown. (B) Schematic presentation of FKBP and FRB binding to rapamycin
text
Banaszynski